CHINO HILLS, Calif. (KABC) -- A Chino Hills family is living with a grim reality. Very few people know what Ataxia is. The neuro-degenerative condition runs in families, and the symptoms can start ...
The modified amino acid levacetylleucine delivered clinically meaningful results in children and adults with the rare ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The trial will evaluate VO659, an antisense ...
SOUTH SAN FRANCISCO, Calif., December 15, 2025--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own ...
Please provide your email address to receive an email when new articles are posted on . Approximately 5,000 people in the United States have Friedreich’s ataxia. Advocates virtually met with ...
IND Application Submitted to Expand RESTORE-FA Trial to U.S. Sites; Notice Received from FDA Placing Clinical Hold on IND Application to Open U.S. Sites CARLSBAD, Calif., June 04, 2025 (GLOBE NEWSWIRE ...
In total, 76 patients with CA (n=28) or HSP (n=48) were included for clinical exome sequencing. The cohort was largely nonconsecutive. Patients with a visiting history from our center were selected ...
Friedrich’s ataxia, an ultra-rare disease characterized by progressively worsening muscle function that ultimately leads to death, now has its first FDA-approved therapy. The regulator has given the ...
To describe ocular abnormalities in patients with Friedreich ataxia (FRDA). OCT and low contrast test sensitivity show that the visual pathway is affected in FRDA. However, in most patients there is ...
PLANO, Texas--(BUSINESS WIRE)-- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results